Data / Form D filings / Dermex Pharmaceutical, Inc.
Dermex Pharmaceutical, Inc.: Form D filing
Dermex Pharmaceutical, Inc., a pharmaceuticals company in Englewood, CO, filed a Form D with the SEC in 2012. The latest, on December 13, 2012, reports $25,000 sold of a $300,000 offering to 2 investors.
Find out what Dermex Pharmaceutical, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 14550 EAST EASTER AVEUNE, SUITE 300, Englewood, CO, 80112
- Phone
- (303) 358-0371
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Colorado
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1564270
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 13, 2012 | New notice | $300,000 | $25,000 | $275,000 | 2 | Dec 3, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Carl Hanson | Executive Officer, Director | |
| Dan Cleveland, Jr | Director | |
| Michael Solhaug | Executive Officer | |
| Frank Potestio, II | Executive Officer, Director |
Every Form D from the week of Dec 10, 2012 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Dermex Pharmaceutical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.